IBDEI0QM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13133,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,13134,0)
 ;;=V10.83^^87^830^74
 ;;^UTILITY(U,$J,358.3,13134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13134,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,13134,1,5,0)
 ;;=5^Personal h/o Skin Cancer
 ;;^UTILITY(U,$J,358.3,13134,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,13135,0)
 ;;=V15.1^^87^830^51
 ;;^UTILITY(U,$J,358.3,13135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13135,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,13135,1,5,0)
 ;;=5^Personal h/o Heart Surgery
 ;;^UTILITY(U,$J,358.3,13135,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,13136,0)
 ;;=V15.82^^87^830^79
 ;;^UTILITY(U,$J,358.3,13136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13136,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,13136,1,5,0)
 ;;=5^Personal h/o Tobacco Use
 ;;^UTILITY(U,$J,358.3,13136,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,13137,0)
 ;;=V12.01^^87^830^77
 ;;^UTILITY(U,$J,358.3,13137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13137,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,13137,1,5,0)
 ;;=5^Personal h/o TB
 ;;^UTILITY(U,$J,358.3,13137,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,13138,0)
 ;;=V12.51^^87^830^81
 ;;^UTILITY(U,$J,358.3,13138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13138,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,13138,1,5,0)
 ;;=5^Personal h/o Venous Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,13138,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,13139,0)
 ;;=V17.89^^87^830^25
 ;;^UTILITY(U,$J,358.3,13139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13139,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,13139,1,5,0)
 ;;=5^Family h/o Musculosk Dis
 ;;^UTILITY(U,$J,358.3,13139,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,13140,0)
 ;;=V12.54^^87^830^76
 ;;^UTILITY(U,$J,358.3,13140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13140,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,13140,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,13140,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,13141,0)
 ;;=V15.88^^87^830^50
 ;;^UTILITY(U,$J,358.3,13141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13141,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,13141,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,13141,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,13142,0)
 ;;=V15.52^^87^830^80
 ;;^UTILITY(U,$J,358.3,13142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13142,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,13142,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,13142,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,13143,0)
 ;;=V12.55^^87^830^70
 ;;^UTILITY(U,$J,358.3,13143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13143,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,13143,1,5,0)
 ;;=5^Personal h/o Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,13143,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,13144,0)
 ;;=V58.61^^87^830^1
 ;;^UTILITY(U,$J,358.3,13144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13144,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,13144,1,5,0)
 ;;=5^Anticoag Rx,Chronic
 ;;^UTILITY(U,$J,358.3,13144,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,13145,0)
 ;;=V12.72^^87^830^2
 ;;^UTILITY(U,$J,358.3,13145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13145,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,13145,1,5,0)
 ;;=5^Colon Polyps (Removed)
 ;;^UTILITY(U,$J,358.3,13145,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,13146,0)
 ;;=V25.09^^87^830^3
 ;;^UTILITY(U,$J,358.3,13146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13146,1,4,0)
 ;;=4^V25.09
 ;;^UTILITY(U,$J,358.3,13146,1,5,0)
 ;;=5^Contraceptive Counseling
 ;;^UTILITY(U,$J,358.3,13146,2)
 ;;=^87608
